Chargement en cours...
Therapeutic Antibodies for the Treatment of Pancreatic Cancer
Pancreatic cancer is a devastating disease with the worst mortality rate and an overall 5-year survival rate lower than 5%. In the U.S., this disease is the fourth leading cause of death and represents 6% of all cancer-related deaths. Gemcitabine, the current standard first-line treatment, offers ma...
Enregistré dans:
| Auteurs principaux: | , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
TheScientificWorldJOURNAL
2010
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2925140/ https://ncbi.nlm.nih.gov/pubmed/20563534 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1100/tsw.2010.103 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|